BCG vaccination of neonatal calves: potential roles for innate immune cells in the induction of protective immunity
Bovine tuberculosis is a disease of increasing incidence in the UK causing major economic losses and with significant impact on bovine and, potentially human health: the causative agent Mycobacterium bovis is a zoonotic pathogen. Neonatal vaccination with the attenuated M. bovis Bacille Calmette Guerin (BCG) vaccine confers a significant degree of protection in cattle, and is a widely used control strategy for human TB. The adaptive immune system is relatively immature in neonates and increased numbers of innate effector cells present in young animals and human infants may compensate for this, enabling effective immune responses to vaccination. Natural killer cells and subsets of ?? TCR+ T lymphocytes secrete high levels of interferon gamma and can interact with antigen presenting cells to promote both innate and adaptive immune responses. These cell populations may be pivotal in determining immune bias following neonatal vaccination with BCG
Back to publications
Publication
Contributors
Siddiqui N, Price S, Hope J
Year
2012
Journal
Comparative Immunology Microbiology and Infectious Diseases
Volume
35
Issue
3
Pages
219-226
Altmetric details